Connect with us

Marijuana Stocks

Licensed Canadian Cannabis Extraction Company MediPharm Labs Posts Profit for Q2 2019

Jeanne Dininni



Licensed Canadian Cannabis Extraction Company MediPharm Labs Posts Profit for Q2 2019

While many investors await the news about quarterly losses, MediPharm has already posted their second quarter profits ahead of the launch of Cannabis 2.0 products. The company reported a profit of $4 million ahead of the legalization of edibles, vaporizers, and other products. The Barrie, ON company received its cannabis oil production licence prior to adult-use legalization under Health Canada’s medical marijuana program. MediPharm is also considered a leader in research, extraction, distillation, purification, and cannabinoid isolation.

MediPharm is ramping up for the next phase of legalization in Canada and has launched Cannabis 2.0. They are also the supplier for Cronos Group with approximately $30 million of cannabis concentrate over 18 months. Additionally, the company is expecting to receive European Union GMP certification to expand into the EU market. The annual capacity is predicted to increase over 500,000 kilograms later this year. In other international markets, MediPharm has secured permits to import medical cannabis concentrate to Australia. MediPharm is also staged to open a manufacturing facility in Melbourne that will have the ability to process up to 75,000 kg of dried cannabis annually.

The future of the company is hopeful, and they recently secured a spot in the Toronto Stock Exchange. They will continue to ramp up production and expect an increase in demand with the further legalization in Canada coming up in October. The company works with Canopy Growth and Supreme Cannabis. They supply Wiz Khalifa’s company Khalifa Kush Enterprises with its high THC oil products. Some are worried of their long-term growth as some companies have started building their own extraction labs. However, with business prospects in Latin America, the Caribbean, Europe, and South Africa, the company is set to continue to do well.

Jeanne Dininni knows the wisdom of the writing industry and has locked arms with us to continue discovering and uncovering all things CBD and hemp. TOC welcomes her work as being humorous and entertaining on top of informative and authoritative.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Follow Times of CBD News

popular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.


Trending CBD News